Compare Stocks: HUM vs. MOH vs. OSCR vs. CLOV

Market Snapshot

Current market context for the selected companies.

HUM

$406.04

Market Cap $48.15B

Sector Healthcare

Industry Healthcare Plans

Data through 2026-09-03

MOH

$202.54

Market Cap $10.58B

Sector Healthcare

Industry Healthcare Plans

Data through 2026-09-03

OSCR

$32.30

Market Cap $9.36B

Sector Healthcare

Industry Healthcare Plans

Data through 2026-09-03

CLOV

$4.26

Market Cap $2.28B

Sector Healthcare

Industry Healthcare Plans

Data through 2026-09-03

Performance

Absolute returns and relative performance versus SPY.

Metric	HUM	MOH	OSCR	CLOV
1 Month	+11.6%	+3.8%	+7.3%	+2.9%
1 Month vs SPY	+11.3%	+3.4%	+6.9%	+2.5%
3 Months	+16.1%	+5.0%	+36.8%	+6.8%
3 Months vs SPY	+14.0%	+3.0%	+34.8%	+4.7%
6 Months	+124.6%	+37.1%	+124.4%	+105.8%
6 Months vs SPY	+111.2%	+23.7%	+111.0%	+92.4%
1 Year	+30.1%	+14.4%	+82.7%	+60.2%
1 Year vs SPY	+10.1%	-5.6%	+62.6%	+40.1%
2 Years	+15.6%	-42.2%	+81.3%	+51.1%
2 Years vs SPY	-22.8%	-80.6%	+42.9%	+12.7%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric	HUM	MOH	OSCR	CLOV
Revenue Growth	26.2%	-5.7%	70.4%	55.6%
Earnings Growth	27.1%	-75.3%	—	—
Gross Margin	13.7%	8.4%	20.2%	18.5%
Operating Margin	3.5%	1.4%	8.0%	3.8%
Net Margin	0.9%	-0.0%	3.6%	-0.7%
Return on Equity	6.9%	-0.2%	34.3%	-5.1%
Return on Assets	3.9%	1.2%	4.5%	-1.8%

Valuation

Common valuation multiples shown side by side.

Metric	HUM	MOH	OSCR	CLOV
P / E	37.3	1,269.1	22.9	—
Forward P / E	24.2	20.8	16.1	28.7
P / S	0.3	0.2	0.6	0.9
P / B	2.5	2.5	4.5	6.0
EV / Sales	0.3	0.1	0.1	0.8
EV / EBIT	7.3	9.1	0.9	21.9
P / FCF	24.4	15.1	13.3	33.1
FCF Yield	4.1%	6.6%	7.5%	3.0%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric	HUM	MOH	OSCR	CLOV
Free Cash Flow	$1.94B	$700.25M	$692.53M	$69.05M
Operating Cash Flow	$2.54B	$365.00M	$4.42B	$77.03M
Debt / Equity	76.5%	94.8%	23.5%	—

Earnings Outlook

Upcoming earnings expectations when available.

Metric	HUM	MOH	OSCR	CLOV
Next Earnings	2026-11-06	2026-10-21	2026-11-09	2026-11-04
EPS Estimate	-0.94	0.83	-0.25	0.01
Revenue Estimate	40.88B	10.86B	4.73B	738.18M
EPS Growth	-129.0%	-54.9%	+53.6%	+203.0%
Revenue Growth	+25.2%	-5.4%	+58.4%	+48.6%
Analyst Coverage	23	18	9	1